Proactive Investors - Run By Investors For Investors

Collagen Solutions rises as it launches new online store

The online store will sell standard collagen products directly to end users in the research market
Collagen Solutions manufactures and supplies collagen for use in regenerative medicine and other medical research

Shares in Collagen Solutions PLC (LON:COS) edged higher on Monday morning after the medical grade collagen manufacturer launched a new business-to-consumer (B2C) web-based business in the US.

The online store will sell standard collagen products directly to end users in the research market.

The Minneapolis-headquartered group called the online offering an “important initiative” as it directly connects COS with its end users and allows it to better understand and address the purchasing needs of researchers.

The company told investors that, in the longer-term, that should help it to make sure it’s supplying the right products to the right markets, the company told investors.

“This initiative serves three purposes for Collagen Solutions,” said chief executive Jamal Rushdy.

“First, it increases our access to the estimated US$200m global market for cell culture reagents.

“Secondly, it gives us a direct link with the end users of our products so that we can understand their needs and how the market for collagen is evolving.

“Finally, it establishes Collagen Solutions as the go-to collagen supplier among investigators.”

Shares gained 5% to 5.14p on Monday morning.

View full COS profile

Collagen Solutions PLC Timeline

Related Articles

picture of drug research
February 20 2017
“The positive results from this feasibility award may lead to other opportunities to secure additional funding awards to advance the programme further," Dr John Reader, Sareum's chief scientific officer said.
Proteomics International Laboratories: Access latest PPT from Proactive's CEO Sessions
April 13 2017
Richard Lipscombe talked revenue generation and growth path with investors.
Paradigm Biopharmaceuticals [JOHN TO UPDATE] at Proactive's Spotlight CEO Sessions
Find out more from Paul Rennie at Proactive's CEO Sessions.

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use